156 related articles for article (PubMed ID: 16598281)
1. Inserting optimism into gene therapy.
Naldini L
Nat Med; 2006 Apr; 12(4):386-8. PubMed ID: 16598281
[No Abstract] [Full Text] [Related]
2. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
Ott MG; Schmidt M; Schwarzwaelder K; Stein S; Siler U; Koehl U; Glimm H; Kühlcke K; Schilz A; Kunkel H; Naundorf S; Brinkmann A; Deichmann A; Fischer M; Ball C; Pilz I; Dunbar C; Du Y; Jenkins NA; Copeland NG; Lüthi U; Hassan M; Thrasher AJ; Hoelzer D; von Kalle C; Seger R; Grez M
Nat Med; 2006 Apr; 12(4):401-9. PubMed ID: 16582916
[TBL] [Abstract][Full Text] [Related]
3. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer to hematopoietic cells--the clinical experience.
Richter J
Eur J Haematol; 1997 Aug; 59(2):67-75. PubMed ID: 9293853
[No Abstract] [Full Text] [Related]
5. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
6. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
[TBL] [Abstract][Full Text] [Related]
7. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
8. [Breakthrough in gene therapy? Interview by Friederike Klein].
Grez M
MMW Fortschr Med; 2006 Apr; 148(17):16. PubMed ID: 16711482
[No Abstract] [Full Text] [Related]
9. Gene therapy for X-linked chronic granulomatous disease.
Haematologica; 2000 May; 85(5):450. PubMed ID: 10800157
[No Abstract] [Full Text] [Related]
10. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
Kaiser J
Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
[No Abstract] [Full Text] [Related]
11. Gene therapy for primary immunodeficiencies: Part 2.
Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
[TBL] [Abstract][Full Text] [Related]
12. [Prospects for gene therapy for chronic granulomatous disease with gp91-phox deficiency].
Nunoi H; Sugimoto Y; Kanegasaki S
Rinsho Ketsueki; 1998 Feb; 39(2):132. PubMed ID: 9545823
[No Abstract] [Full Text] [Related]
13. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
[TBL] [Abstract][Full Text] [Related]
14. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
15. Reducing the genotoxic potential of retroviral vectors.
Ramezani A; Hawley TS; Hawley RG
Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646
[TBL] [Abstract][Full Text] [Related]
16. Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer.
Weil WM; Linton GF; Whiting-Theobald N; Vowells SJ; Rafferty SP; Li F; Malech HL
Blood; 1997 Mar; 89(5):1754-61. PubMed ID: 9057660
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease.
Dunbar CE
Annu Rev Med; 1996; 47():11-20. PubMed ID: 8712765
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for chronic granulomatous disease.
Ryser MF; Roesler J; Gentsch M; Brenner S
Expert Opin Biol Ther; 2007 Dec; 7(12):1799-809. PubMed ID: 18034646
[TBL] [Abstract][Full Text] [Related]
19. Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
Kang HJ; Bartholomae CC; Paruzynski A; Arens A; Kim S; Yu SS; Hong Y; Joo CW; Yoon NK; Rhim JW; Kim JG; Von Kalle C; Schmidt M; Kim S; Ahn HS
Mol Ther; 2011 Nov; 19(11):2092-101. PubMed ID: 21878903
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of chronic granulomatous disease.
Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
